Artal Group’s Krystal Biotech KRYS Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-349,669	Closed	-$41.1M	–	107
2023 Q2	$41.1M	Sell	349,669 -62,413	-15%	-$7.33M	1.27%	14
2023 Q1	$33M	Buy	412,082 +12,082	+3%	+$967K	1.96%	15
2022 Q4	$31.7M	Sell	400,000 -100,000	-20%	-$7.92M	1.77%	15
2022 Q3	$34.9M	Hold	500,000	–	–	1.49%	20
2022 Q2	$32.8M	Hold	500,000	–	–	1.75%	17
2022 Q1	$33.3M	Sell	500,000 -200,000	-29%	-$13.3M	1.39%	18
2021 Q4	$49M	Buy	700,000 +200,000	+40%	+$14M	1.33%	17
2021 Q3	$26.1M	Hold	500,000	–	–	0.58%	38
2021 Q2	$34M	Hold	500,000	–	–	0.69%	27
2021 Q1	$38.5M	Buy	500,000 +262,500	+111%	+$20.2M	0.68%	25
2020 Q4	$14.3M	Hold	237,500	–	–	0.31%	69
2020 Q3	$10.2M	Buy	237,500 +37,500	+19%	+$1.61M	0.25%	65
2020 Q2	$8.28M	Buy	200,000 +100,000	+100%	+$4.14M	0.23%	64
2020 Q1	$4.32M	Buy	100,000 +20,000	+25%	+$865K	0.18%	68
2019 Q4	$4.43M	Sell	80,000 -70,000	-47%	-$3.88M	0.17%	66
2019 Q3	$5.21M	Sell	150,000 -150,000	-50%	-$5.21M	0.21%	60
2019 Q2	$12.1M	Hold	300,000	–	–	0.49%	36
2019 Q1	$9.87M	Buy	300,000 +25,000	+9%	+$823K	0.4%	40
2018 Q4	$5.72M	Buy	275,000 +125,000	+83%	+$2.6M	0.21%	43
2018 Q3	$2.64M	Hold	150,000	–	–	0.07%	72
2018 Q2	$2.23M	Hold	150,000	–	–	0.05%	69
2018 Q1	$1.51M	Hold	150,000	–	–	0.02%	71
2017 Q4	$1.58M	Buy	150,000 +50,000	+50%	+$526K	0.02%	66
2017 Q3	$997K	Buy	+100,000	New	+$997K	0.02%	76